Brainstorm Cell Therapeutics Inc. (BCLI) rose 29.7% or 0.9 to $3.93. It is about 667391 shares traded, which is 764.71% compare to the average total volume 87274. The market cap of BCLI is $74.05 million. The year to date change is 18.36%. The 52 week price range is from $2.48 to $5.18. Price of BCLI have changed -9.82% during last week. It have changed -22.90% over last month, -25.00% over last 3 months, -31.14% over last 6 months and 13.06% over one year.
Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for BCLI is 3.99. It is 1.53% above current price. The 200-day Moving Averages for BCLI is 4.14. It is 5.34% above current price. The 52-week High is 5.18. It is 31.81% from the current price. The 52-week Low is 2.48. It is -36.90% from current price.
Some people may be interesting about short interest ratio of a stock. The short interest ratio of BCLI is 18.67 on 2017-11-30. Short % to float is 7.20%. There are some statistics of BCLI. It is has market cap $74.05 million. The share outstanding is 18.84 million. The average volume is 87274. The percent of top 15 Institution holding is 5.60%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of BCLI is -74.44%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of BCLI is -50.76%.